Life Saving Drugs Program – Avalglucosidase alfa (Nexviazyme®) outcome statement
About this resource
Publication date:
Publication type:
Fact sheet
Audience:
General public
Language:
English
Australian Government Department of Health, Disability and Ageing
Life Saving Drugs Program – Avalglucosidase alfa (Nexviazyme®) outcome statement
Summary of the consideration of the application from Sanofi Pty Ltd for the inclusion of avalglucosidase alfa (Nexviazyme®) on the Life Saving Drugs Program (LSDP) for the treatment of Pompe Disease.